Faeth Therapeutics strengthens its leadership team with the appointment of Dr. Stephen Hahn, a renowned radiation oncologist and former Chief Medical Executive of MD Anderson Cancer Center, and Dr. Jayson Dallas, an accomplished biotech leader and former CEO of Aimmune Therapeutics, to its Board of Directors

Rather the company is aiming to interrogate how nutrition can become a “fifth pillar” of cancer care through scientific study. The company also has another trial aimed at metastatic colorectal cancer.

Faeth Therapeutics Appoints Dr. Stephen Hahn As Chief Medical Executive and Dr. Jayson Dallas As Chief Executive Officer

Faeth Therapeutics Appoints Dr. Stephen Hahn As Chief Medical Executive and Dr. Jayson Dallas As Chief Executive Officer

Company Info

Related People